Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Variable drug metabolism genes in Arab population

The Pharmacogenomics Journal volume 4, pages 260–266 (2004)Cite this article

Abstract

Cataloging interethnic differences in the distribution of genotypes of drug metabolic genes provides valuable information for profiling the pharmacogenetics of a population. We used PCR analysis to catalog the frequencies of alleles and genotypes for CYP1A1, NAT2, GSTs, MTHFR, MTR (MS) and NQO*1 in Arabs. The frequencies of alleles and/or genotypes for CYP1A1*2A, GSTT1 null, GSTT1 and GSTM1 double null, and GSTP1 A1578G in Arabs were significantly higher than those reported in Caucasians. However, the distribution of NAT2 acetylator phenotypes in both populations was similar. In contrast, the frequencies of MTHFR 677T allele and the combined (677+1298) genotypes for low activity were lower than those reported in Caucasians. Other alleles in Arabs, including CYP1A1 T3801C and GSTP1 A1578G were present in frequencies similar to Africans. The overall profile of variations in metabolism genes in Arabs is thus unique.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M . Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 2002; 100: 3832–3834.

    Article  PubMed  Google Scholar 

  2. Sekine I, Saijo N . Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Ann Oncol 2001; 12: 1515–1525.

    Article  CAS  PubMed  Google Scholar 

  3. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 2002; 99: 754–758.

    Article  CAS  PubMed  Google Scholar 

  4. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ . A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654–8658.

    CAS  PubMed  Google Scholar 

  5. Relling MV, Dervieux T . Pharmacogenetics and cancer therapy. Nat Rev Cancer 2001; 1: 99–108.

    Article  CAS  PubMed  Google Scholar 

  6. Nebert DW, McKinnon RA, Puga A . Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 1996; 15: 273–280.

    Article  CAS  PubMed  Google Scholar 

  7. Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002; 8: 802–810.

    CAS  PubMed  Google Scholar 

  8. Krajinovic M, Labuda D, Sinnett D . Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome. Rev Environ Health 2001; 16: 263–279.

    Article  CAS  PubMed  Google Scholar 

  9. Davies SM, Robison LL, Buckley JD, Tjoa T, Woods WG, Radloff GA et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001; 19: 1279–1287.

    Article  PubMed  Google Scholar 

  10. Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000; 10: 715–726.

    Article  CAS  PubMed  Google Scholar 

  11. Sabbagh N, Delaporte E, Marez D, Lo-Guidice JM, Piette F, Broly F . NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus. Pharmacogenetics 1997; 7: 131–135.

    Article  CAS  PubMed  Google Scholar 

  12. Toffoli G, Cecchin E . Pharmacogenetics of stomach cancer. Suppl Tumori 2003; 2: S19–S22.

    PubMed  Google Scholar 

  13. Chiusolo P, Reddiconto G, Casorelli I, Laurenti L, Sora F, Mele L et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol 2002; 13: 1915–1918.

    Article  CAS  PubMed  Google Scholar 

  14. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239–1248.

    CAS  PubMed  Google Scholar 

  15. Robien K, Ulrich CM . 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003; 157: 571–582.

    Article  PubMed  Google Scholar 

  16. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG . NAD(P)H : quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002; 4: 62–70.

    Article  CAS  PubMed  Google Scholar 

  17. Chabner BA . Cytotoxic agents in the era of molecular targets and genomics. Oncologist 2002; 7: 34–41.

    Article  CAS  PubMed  Google Scholar 

  18. Sawyer MB, Innocenti F, Das S, Cheng C, Ramirez J, Pantle-Fisher FH et al. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003; 73: 566–574.

    Article  CAS  PubMed  Google Scholar 

  19. Perentesis JP . Genetic predisposition and treatment-related leukemia. Med Pediatr Oncol 2001; 36: 541–548.

    Article  CAS  PubMed  Google Scholar 

  20. Nowell S, Sweeney C, Winters M, Stone A, Lang NP, Hutchins LF et al. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 2002; 94: 1635–1640.

    Article  CAS  PubMed  Google Scholar 

  21. Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 2001; 98: 11592–11597.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000; 6: 4091–4095.

    CAS  PubMed  Google Scholar 

  23. Tew KD . Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313–4320.

    CAS  PubMed  Google Scholar 

  24. Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C . Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab Dispos 1991; 19: 625–629.

    CAS  PubMed  Google Scholar 

  25. Lisowsky I . High capacity binding by glutathione S-tranferases and glucocorticoid resistance. In: Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD (eds). Structure and Function of Glutathione Transferases. CRC Press: Boca Raton, FL 1993; pp 199.

    Google Scholar 

  26. Celander M, Hahn ME, Stegeman JJ . Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A. Arch Biochem Biophys 1996; 329: 113–122.

    Article  CAS  PubMed  Google Scholar 

  27. Celander M, Weisbrod R, Stegeman JJ . Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture. Biochem Biophys Res Commun 1997; 232: 749–753.

    Article  CAS  PubMed  Google Scholar 

  28. Innocenti F, Iyer L, Ratain MJ . Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab Dispos 2001; 29: 596–600.

    CAS  PubMed  Google Scholar 

  29. Lucotte G, Loirat F, Hazout S . Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 1997; 69: 253–262.

    CAS  PubMed  Google Scholar 

  30. Haase D, Binder C, Bunger J, Fonatsch C, Streubel B, Schnittger S et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002; 26: 249–254.

    Article  CAS  PubMed  Google Scholar 

  31. Thier R, Bruning T, Roos PH, Rihs HP, Golka K, Ko Y et al. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 2003; 206: 149–171.

    Article  CAS  PubMed  Google Scholar 

  32. Migliore L, Coppede F . Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 2002; 512: 135–153.

    Article  CAS  PubMed  Google Scholar 

  33. McLeod HL, Krynetski EY, Relling MV, Evans WE . Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 567–572.

    Article  CAS  PubMed  Google Scholar 

  34. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 3205–3209.

    Article  CAS  PubMed  Google Scholar 

  35. Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK . Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 289–292.

    CAS  PubMed  Google Scholar 

  36. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D . Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999; 93: 1496–1501.

    CAS  PubMed  Google Scholar 

  37. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I . Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996; 56: 3961–3966.

    CAS  PubMed  Google Scholar 

  38. Cotton SC, Sharp L, Little J, Brockton N . Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000; 151: 7–32.

    Article  CAS  PubMed  Google Scholar 

  39. Coughlin SS, Hall IJ . Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med 2002; 4: 250–257.

    Article  CAS  PubMed  Google Scholar 

  40. Brockton N, Little J, Sharp L, Cotton SC . N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000; 151: 846–861.

    Article  CAS  PubMed  Google Scholar 

  41. Botto LD, Yang Q . 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000; 151: 862–877.

    Article  CAS  PubMed  Google Scholar 

  42. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810–12815.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Song C, Xing D, Tan W, Wei Q, Lin D . Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272–3275.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Fahad National Center for Children’s Cancer and Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    R Bu, M I Gutiérrez, M Al-Rasheed, A Belgaumi & K Bhatia

  2. International Network for Cancer Treatment and Research, Brussels, Belgium

    K Bhatia

Authors
  1. R Bu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M I Gutiérrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Al-Rasheed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Belgaumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Bhatia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Bhatia.

Additional information

DUALITY OF INTEREST

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bu, R., Gutiérrez, M., Al-Rasheed, M. et al. Variable drug metabolism genes in Arab population. Pharmacogenomics J 4, 260–266 (2004). https://doi.org/10.1038/sj.tpj.6500251

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500251

Keywords

This article is cited by

Search

Advanced search

Quick links